共 50 条
[42]
Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
[J].
TRANSPLANTATION AND CELLULAR THERAPY,
2021, 27 (05)
:408.e1-408.e6
[43]
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation
[J].
Bone Marrow Transplantation,
2004, 34
:527-530
[48]
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)
[J].
BONE MARROW TRANSPLANTATION,
2022, 57 (10)
:1556-1563
[50]
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
[J].
BONE MARROW TRANSPLANTATION,
2014, 49 (03)
:389-396